TNFRSF13B and neoplasm: Interestingly, APRIL can promote immune responses in the tumor microenvironment that are beneficial for its growth while inhibiting responses that could lead to the elimination of tumor cells (especially through interaction with the TACI and BCMA receptors) [5,49].